Kala Pharmaceuticals, Inc. (KALA)
NASDAQ: KALA · IEX Real-Time Price · USD
6.76
-0.07 (-1.02%)
At close: Jul 19, 2024, 4:00 PM
6.68
-0.08 (-1.18%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
Kala Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for KALA stock have an average target of 16.5, with a low estimate of 15 and a high estimate of 18. The average target predicts an increase of 144.08% from the current stock price of 6.76.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 17, 2024.
Analyst Ratings
The average analyst rating for KALA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $18 | Strong Buy | Maintains | $21 → $18 | +166.27% | May 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +210.65% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 | Buy | Reiterates | $15 | +121.89% | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $22 | Strong Buy | Maintains | $24 → $22 | +225.44% | Nov 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +255.03% | Aug 11, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-14.78
from -17.35
EPS Next Year
-7.72
from -14.78
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | 26.3M |
| Avg | n/a | n/a | 25.5M |
| Low | n/a | n/a | 24.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -14.29 | -7.95 |
| Avg | -14.78 | -7.72 |
| Low | -15.06 | -7.42 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.